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ABSTRACT
Patient scheduled for adrenalectomy with laparoscopic technique due to a tumor of left adrenal gland. 
The diagnosis of chronic hypertension was difficult blood pressure to control, for that, a battery was 
requested to discard Pheochromocytoma, resulting in a tumor of the left adrenal gland.  Teamwork of the 
specialties involved in patient care, effective communication, pre-surgical preparation and perioperative 
management; resulted in minimal perioperative complications, remained in the intensive care unit for 
one day, and hospital stay was reduced.
Key words: Pheochromocytoma; Laparoscopic adrenalectomy; Perioperative Considerations (source: 
MeSH NLM).
RESUMEN
Paciente programada para una suprarrenalectomía con la técnica laparoscópica, debido a un tumor de la 
glándula suprarrenal izquierda, su diagnóstico  Hipertensión arterial crónica, se volvió difícil de controlar, 
por tal motivo se le solicita batería para descartar Feocromocitoma, resultando portadora de un tumor de 
la glándula suprarrenal izquierdo. El trabajo en equipo de las especialidades involucradas en el cuidado 
de la paciente, la comunicación efectiva, la preparación pre quirúrgica y el manejo periopertorio; dió 
como resultado que la paciente presentara  mínimas complicaciones perioperatorias, permaneció en 
unidad de cuidados intensivos un día y se disminuyó la estancia hospitalaria.
Palabras clave: Feocromocitoma; Suprarrenalectomía laparoscópica; Consideraciones perioperatorias 
(fuente: DeCS BIREME).
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The purpose of this case presentation is to provide an 
analysis of the perioperative approach and effective 
communication between the surgical team before, 
during, and after surgery. Likewise, the perioperative 
considerations since the diagnosis was made, the 
preoperative treatment, the perioperative anesthetic 
considerations, and the surgical implications of 
pheochromocytomas, constitute a challenge for the 
anesthesiologist and the entire medical team. The 
multidisciplinary management allowed us to reduce 
complications and morbimortality, likewise there are 
very few case reports of this pathology published in 
Peru; there is only one report of female patients more 
than 20 years ago, despite the fact that the incidence 
of this pathology is equal between men and women.
CLINICAL CASE
A 62-year-old female patient of mixed race, from 
the city of Lima, underwent laparoscopic left 
adrenalectomy for pheochromocytoma at the 
Clínica Internacional. She had no family history 
of tumor surgeries. As personal history she had 
hypertension for 4 years, dyslipidemia, and 
abdominal hysterectomy and breast biopsy.
Clinical picture: Patient presented headache, anxiety, 
palpitations, but no sweating, approximately 3 months 
before surgery. Her treatment was amlodipine 5 mg/
day, losartan 50 mg/day, spironolactone 25 mg/day, 
hydrochlorthiazide 12,5mg/day, and atorvastatin 10 
mg/day. The patient was prepared 20 days before 
surgery; treatment was started gradually with alpha-
blockers such as terazosin, until reaching a dose 
of 5 mg/day. Losartan was suspended when she 
presented hypotension during treatment; likewise, 
5 days before the operation, she received beta-
blockers such as atenolol 50 mg/day. After surgery, 
she required only the antihypertensive amlodipine 
5mg/day.
DIAGNOSTIC TESTS
Pre-surgical profile: hemoglobin 12.4g/dL, normal 
blood count, platelets 362,000, glucose 80mmHg, 
urea 31mg/dL, creatinine 0.70mg/dL, blood group 
O+, clotting time 7.30 minutes, bleeding time 2. 
15minutes, plasma metanephrines 46.0 pg/mL, 
normetanephrines180pg/mL, urine metanephrines 
0.25mg/24hours, metanephrines/creatinine ratio 
0.28, 24-hour urine free catecholamines 65.0ug/24h.
Chest X-ray: parahilar bronchiectasis in right 
hemithorax.
Multislice tomography of abdomen and pelvis 
(Figure 2): left adrenal gland, nodular morphology 
formation is observed, well defined contours of 4 
cm, major diameter, low density nodule measuring 
on average 10 HUH.
MRI: Heterogeneous expansive formation, 
dependent on the left adrenal gland, is replaced 
by a heterogeneous tumor with well-defined 
borders, with a larger diameter of 4.6 cm. There is 
no alteration of the peritumoral fat, nor infiltration 
of the underlying structures. After the contrast 
substance, heterogeneous enhancement, no 
infiltration. (Figure 3)
Echocardiogram: EF: 60%. Diastolic dysfunction, mild 
LV hypertrophy predominantly septal, preserved 
systolic function.
Surgical risk: ASAIII. Intermediate Pneumological 
Risk.
Patient was evaluated in preanesthesia care unit, two 
days before the operation by the anesthesiologist. The 
patient signed the informed consent for anesthesia. 
When exploring the airway, Mallampati: II, good oral 
opening and cervical mobility, thyromental distance 
grade I, bite test class II.
Physical Examination: Skin and mucous membranes 
pallor, apparatus and systems within normal limits.
The patient was hospitalized one night before 
surgery and was evaluated the day of surgery by 
the anesthesiologist on duty (second evaluation of 
anesthesia) who made the pre-anesthesia record. No 
premedication is indicated.
On the day of surgery, the patient enters the 
operating room with both informed consents, 
the specialized surgical one and the anesthesia 
one. She was monitored and anesthesia checklist 
was performed. Monitoring was done with EKG 
(electrocardiographic monitoring), non-invasive 
blood pressure, oxygen saturation, capnography, 
intra-arterial catheter was placed to measure 
invasive blood pressure and central venous catheter 
to measure central venous pressure. Anesthetic 
induction was then performed with fentanyl citrate 
7 ug/kg, propofol 2 mg/kg, and rocuronium 0.6 mg/
kg.  Endotracheal intubation was performed without 
complications, nasogastric tube and esophageal 
thermometer were placed. She received balanced 
general anesthesia, maintained with remifentanil 
0.50- 0.20ug/kg/minute, ultra-short-acting opioid 
and sevofluorane 1%.  Intraoperatively, she required 











minimal doses of sodium nitroprusside 0.1- 0.2 
ug/kg/min during gland manipulation, and two 
doses of phenylephrine 2- 3 ug/kg STAT after gland 
removal. Before extubation, sugammadex 2mg/
kg was administered to reverse the neuromuscular 
blockade. Intraoperative glycemia was measured 
twice in the operating room; the result was normal.
For postoperative analgesia, multimodal analgesia 
was used with ketoprofen 1.5mg/kg and tramadol 1 
mg/kg.
Before starting the surgical procedure, the second 
part of the check list was performed; the technique 
used by the surgeon will be commented in the 
discussion.  Approximately after 2 hours, the surgery 
was finished and the last part of the checklist 
was performed. The patient is extubated without 
complications, goes to the ICU (intensive care unit) 
awake, calm, with stable vital functions and no pain.
In the immediate postoperative period, after 8 
hours of her stay in the ICU, the patient presented 
hypoxemia, oxygen saturation 87%, and pulmonary 
congestion. She was treated with furosemide 
20mg/12; she also presented mild hyperglycemia. 
The patient remained stable and was discharged to 
her floor the following day, in hospitalization she did 
not present any complication and was discharged 
two days later after presenting a favorable clinical 
evolution.
Figure 1. Intraoperative monitoring of hemodynamic variables.









Figure 2. ICT with venous phase contrast.
Figure 3. Magnetic resonance imaging of the left adrenal gland.












Pheochromocytoma is a rare neuroendocrine tumor 
derived from the embryonic neural crest, which 
produces catecholamines, mainly in the chromaffin 
cells of the adrenal medulla or in extra-adrenal 
paraganglioma chromaffin tissue(1,2,3).
It has an incidence of 0,4 to ,5 new cases per 
100,000 in adults, and occurs in 0,1 to 1%(4) of 
patients with arterial hypertension; our patient is 
included in this group. The literature reports that, 
of the pheochromocytomas discovered at autopsy, 
75% died suddenly of myocardial infarction or 
cerebrovascular catastrophe; 1/3 of sudden deaths 
occurred during or immediately after a minor 
operation(1).
The patient's diagnosis included plasma fractionated 
metanephrines screening, a study that has a 
sensitivity of 98% for adrenal and 94 vs 90% for extra-
adrenal(5), as well as 24-hour urine metanephrines 
and catecholamines, with plasma normetanephrine 
being found at the upper limit.
As for the localization diagnosis, computed axial 
Figure 4. Surgical technique showing laparoscopic dissection of the left pheochromocytoma.
tomography and magnetic resonance imaging (MRI) 
were used, where the left adrenal gland-dependent 
tumor was evidenced.
Preparation for surgery of patients diagnosed with 
pheochromocytoma should begin at least 2 weeks 
before surgery, to allow complete alpha adrenergic 
blockade; this single precaution can decrease 
perioperative mortality from 43% to 3%(4).
Pre-surgical preparation for pheochromocytoma 
surgery is essential for an optimal outcome, the 
standard protocol(6) is with phenoxybenzamine; 
it does not currently exist in the national market, 
but we do have others such as the selective alpha 
antagonist terazosin, which was used in it and 
serves to prevent life-threatening cardiovascular 
complications, such as hypertensive crises, 
arrhythmias, myocardial infarction and pulmonary 
edema. Five days before surgery, treatment with 
beta-blockers was initiated, which should not be 
started before a good alpha blockade has been 
achieved(7,8,9) and never in the absence of alpha-
blockers. This is because it could cause an increase 
in catecholamine-induced vasoconstriction, 









unopposed deep alpha vasoconstriction, which may 
lead to hypertensive crisis or pulmonary edema. 
From the surgical decision of the patient there must 
be good communication and teamwork between 
the treating physician, in this case cardiologist, 
with the specialized urologist surgeon and the 
anesthesiologist, before the patient is scheduled, to 
avoid suspensions of surgeries and prevent adverse 
events during the perioperative period.
Likewise, it is very important that the anesthesiologist 
who will attend the patient is the one who evaluates 
her, identifies and assesses all additional risk factors, 
establishes the patient-physician relationship, or if 
she needs an interconsultation to another specialty, 
educates the patient and explains the anesthesia 
procedure. These processes can be concretized with 
interprofessional care flows and care processes that 
are established in the institution.
Premedication, the night before or the day of 
surgery, is not part of our care protocols because 
of the risk of postoperative cognitive dysfunction. 
This is especially true in patients over 60 years, when 
adding the effects of anxiolytics or sedatives used to 
the effects of hypnotics used during anesthesia.
Intraoperative considerations include avoiding 
factors that may trigger a hypertensive crisis(10), such 
as superficial anesthesia during tracheal intubation(4) 
and during surgery. We must be aware of all factors, 
such as tumor compressions, patient positioning, 
intraperitoneal insufflations of carbon dioxide, 
and during laparoscopy, direct manipulation of 
the tumor, which could trigger a hypertensive 
crisis. Similarly, avoid anticholinergic drugs such as 
atropine, sympathomimetics such as pancuronium 
bromide, drugs that release histamine such as 
morphine, atracurium besylate and others such as 
droperidol, halothane, defluorane(2).
Pre-load was monitored by measuring central venous 
pressure, according to institutional guidelines. Other 
authors, such as(11), propose monitoring preload by 
measuring systolic volume variations in patients 
undergoing laparoscopic adrenalectomy.
The anesthetic management was with balanced 
anesthesia, and the anesthetic induction was with 
moderate doses of opiate, to avoid pain response 
during endotracheal intubation, and propofol, 
which is a hypnotic with a protective profile for 
these patients. Likewise, it is advisable to have 
sodium nitroprusside ready because of the risk of 
catecholamine increase, as happened in this case 
during resection. (Figure 1) An alpha vasoconstrictor 
such as Phenylephrine or Noradrenaline should also 
be available. In Peru, it is difficult to have access to 
phenylephrine drug because it is not commercialized; 
it has a potent alpha effect that causes immediate 
recovery from hypotension. This drug was available 
in the institution, therefore 2 boluses were applied 
and it was enough.
Peridural conductive anesthesia with catheter was 
used for laparotomies of suprarenalectomies and 
for postoperative pain control; it should be noted 
that its use is controversial because patients may 
present regurgitations or aspirations. In the case of 
laparoscopies, capnography must be obligatorily 
measured, therefore it is advisable to use balanced 
general anesthesia.
The laparoscopic technique has rapidly become the 
standard for the treatment of these tumors, however, 
this depends on the size of the tumor which must be 
< 6 cm(12). The laparoscopic approach is associated 
with shorter hospital stay, less use of analgesics, 
less postoperative pain, less hemodynamic effects, 
lower levels of circulating catecholamines, and less 
morbidity than laparotomies.
As for the treatment, a minimally invasive 
laparoscopic approach was used, since the tumor 
measured < 6 cm, the surgical technique used by 
the urologist was by transperitoneal access. He 
first dissected the mesocolon and Gerota’s fascia, 
identifying the gonadal vein up to the renal vein to 
facilitate access to it. He also avoided dissection of 
the adrenal gland before ligation of the vein, which 
must always be ligated first to avoid release of 
catecholamines. In that sense, he ligated the adrenal 
vein with 10mm Hem-o-lock, transected the adrenal 
vein and performed the removal of the adrenal gland 
in a laparoscopic extractor bag. Figure 4.
Surgical resection is the mainstay of treatment, but 
patients are at risk of presenting many complication 
(13,14,15).
The prognosis was favorable, there was no 
recurrence after two years of follow-up, the patient 
almost regularized her blood pressure, and currently 
continues to use minimal doses of antihypertensive 
medication.
Preoperative, intraoperative and postoperative 
medical, pharmacological and surgical management 
of pheochromocytoma constitute challenges for the 
medical team, which must be multidisciplinary and 
constitute the path to achieve a successful outcome.












An effective and timely communication between 
the surgeon, anesthesiologist and cardiologist, 
an adequate preoperative preparation, as well as 
the use of minimally invasive surgical techniques 
as described in the report and in the anesthetic 
techniques, result in minimizing perioperative 
complications and adverse events, improving the 
prognosis of patients requiring pheochromocytoma 
surgery. In our country, we need more scientific 
publications of patients with this pathology in order 
to standardize our care processes for the safety of 
our patients.
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